VENOM: when military autonomy becomes a kit rather than an aircraft

On July 16, 2026, DARPA and the US Air Force announced that a production F-16 had flown in June 2026, at Eglin Air Force Base in Florida, under full artificial-intelligence control, with no pilot at the controls. The aircraft carried the VENOM Autonomy Kit (VAK), which allows pilots to toggle in-flight between human and autonomous control — developed under the VENOM program (Viper Experimentation and Next-generation Operations Model), itself a continuation of the Air Combat Evolution (ACE) program and now handed off to the new Artificial Intelligence Reinforcements (AIR) program.

To place the break in context, recall what came before: the X-62A VISTA, a one-of-a-kind, heavily instrumented aircraft, whose conversion and upkeep for autonomous flight represented a non-replicable R&D investment — fixed, bespoke capital tied up in a single airframe. VENOM changes the logic: instead of designing a new aircraft dedicated to autonomy, DARPA installs a detachable kit on several standard-issue, already-depreciated, already-in-service F-16s.

This is a shift toward the economics of modularity, in the sense formalized by Baldwin and Clark (2000): breaking a system into modules connected by stable interfaces lets one component — here, the autonomy kit's software and sensors — evolve independently of the platform that carries it. The benefit isn't only technical; it's economic. A replaceable module turns an ad hoc investment into an industrializable component, duplicated at declining marginal cost across a fleet, rather than rebuilt from scratch for every unit.

This logic echoes an older insight into the economics of industrial standardization: Rosenberg (1963), tracing the emergence of the "American system of manufactures," already showed how interchangeable parts lower the cost of adapting an existing capital stock. Here, the existing capital stock is the fleet of F-16s already built and already paid for; the autonomy kit changes how it is used without requiring a new aircraft program, as purpose-built unmanned aircraft would — such as the future Collaborative Combat Aircraft.

The kit's reversibility — the toggle between human and AI control — carries its own economic value: it preserves an option rather than forcing an irreversible commitment to full autonomy. Facing uncertainty that is both technological (reliability, behavior under real combat conditions) and doctrinal (rules of engagement, crew trust), keeping the ability to revert to human piloting has a price — and VENOM is designed not to give it up.

On the factual side, caution is warranted: DARPA disclosed neither program cost nor the exact number of converted aircraft, framing this step as an expansion of test conditions rather than a budgeted deployment. It would be premature to attach figures to it — but the architectural choice itself is already a clear signal.

For European aerospace and defense manufacturers — maintainers of existing fleets as much as sponsors of collaborative combat drone ("loyal wingman") programs — the lesson extends beyond the US case. It raises a concrete industrial-policy question: is it better to fund autonomy as a new aircraft program, or as a modular component that reuses already-depreciated aeronautical capital? DARPA's choice, documented under real conditions, is worth following as a case study before European programs make their own call.